Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Looks Ahead To 2011, But Avastin Woes And Other Concerns Could Pose Challenges

Feb 02 2011

• By Lisa LaMotta

Related Content

Roche/Ipsen's Suspended Taspoglutide Could Become Another Diabetes Casualty

Sep 10 2010

Genentech May Not Get A Chance To Appeal FDA's Decision To Withdraw Avastin's Breast Cancer Approval

Dec 20 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window